Copyright and DMCA Policy

Effective 2026-07-24

1. What we own

The written guides, original diagrams and illustrations, the icon set, the provider comparison data as compiled and structured, and the design of this site are the work of GLP-1 Healthcare and are protected by copyright. Our identity system is documented on our Brand page.

2. What we do not own, and how we use it

Much of what makes this site useful comes from sources we do not own, and we are deliberate about how we use them:

• US government works. FDA labelling, DailyMed prescribing information, CDC and NIH material are generally not subject to copyright in the United States as works of the federal government. We still cite them, because attribution is about verifiability, not just permission.
• Peer-reviewed research. We report figures and findings and link to the source. Facts and data are not themselves copyrightable; the article expressing them is. We do not reproduce article text beyond brief quotation.
• Brand and product names. Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Saxenda, Victoza, Trulicity, Foundayo and others are trademarks of their respective owners. We use them descriptively to identify the products being discussed. We are not affiliated with, endorsed by, or sponsored by any manufacturer — see How We’re Funded.
• Provider information. Our directory reports each company’s own published terms, with a source link and a verification date, as factual reporting rather than reproduction of their marketing copy.

3. Using our work

You may quote briefly from our guides with attribution and a link to the page quoted. You may not republish substantial portions, mirror the site, or present our work as your own. For anything beyond brief quotation — syndication, translation, classroom or clinical use — email legal@glp1.healthcare. We are generally willing, and we would rather say yes than find out later.

Full terms are in our Terms of Use.

4. Reporting infringement

If you believe material on this site infringes your copyright, send a written notice to copyright@glp1.healthcare including all of the following, as required by 17 U.S.C. §512(c)(3):

1. Your physical or electronic signature.
2. Identification of the copyrighted work you claim has been infringed.
3. Identification of the material you claim is infringing, with enough detail for us to locate it — a direct URL is best.
4. Your name, address, telephone number, and email address.
5. A statement that you have a good-faith belief that the use is not authorised by the copyright owner, its agent, or the law.
6. A statement that the information in your notice is accurate and, under penalty of perjury, that you are the copyright owner or authorised to act on their behalf.

5. What we do with a notice

We review every notice ourselves rather than removing automatically. If material is infringing we will remove or disable it promptly. If we believe the use is lawful — for example, factual reporting, brief quotation, or descriptive use of a trademark — we will tell you why rather than quietly take down accurate health information. Bad-faith notices intended to suppress unfavourable but accurate reporting will be declined, and §512(f) provides for liability where a notice knowingly misrepresents infringement.

6. Counter-notice

If your material was removed and you believe that was a mistake or misidentification, you may send a counter-notice to copyright@glp1.healthcare containing your signature, identification of the removed material and its former location, a statement under penalty of perjury of your good-faith belief that it was removed in error, your contact details, and your consent to the jurisdiction of the appropriate federal court.

7. Corrections are usually the better route

If your concern is that we have described your product, company, or research inaccurately, a correction request will be faster and more effective than a copyright notice. We publish a corrections process in our Editorial Policy and we act on it — email corrections@glp1.healthcare.